Lastly, the above findings were validated with 50 CLL patients from our clinical center Henan Cancer Hospital (HNCH), revealing that both TCF1 and BCL11B participate in the regulation of T cell immunity and further determine the prognosis of patients with CLL. Here, TCF7 is linked to B-cell chronic lymphocytic leukemia.